Inve US ▾
NENEE

NextEra Energy (NEE) Q3 FY26 earnings call

Earnings call· Sep 2026 (Q3 FY26)· Utilities· Oct 21, 2026

Source: earnings call transcript

NextEra Energy delivered strong Q3 FY26 results, driven by robust performance at FPL and Energy Resources, positioning the company to meet its high-end EPS target despite anticipated Q4 wind impacts. The company is actively executing its growth strategy, marked by significant renewables and storage backlog additions, and advancing large-load federal hub projects, while progressing the Dominion Energy merger.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

NEE operating KPIs by quarter

NEE operating KPIs stated on its earnings calls, by fiscal quarter
KPI Dec 2025 Q4 FY25 Mar 2026 Q1 FY26 Jun 2026 Q2 FY26This call Sep 2026 Q3 FY26Change vs prior quarter
Capital expenditures Florida Power & Light Company
~$2.1B FPL's capital expenditures were approximately $2.1 billion in the fourth quarter, bringing its full year capital investments to a total of roughly $8.9 billion. Source: earnings call transcript
~$3.2B FPL's capital expenditures were approximately $3.2 billion for the quarter, and we expect FPL's full year capital investments to be between $12 billion and $13 billion. Source: earnings call transcript
~$2.8B FPL's capital expenditures were approximately $2.8 billion for the quarter, and we expect FPL's full year capital investments to be between $12 billion and $13 billion. Source: earnings call transcript
~$2.4B FPL's capital expenditures were approximately $2.4 billion for the quarter, and we expect FPL's full year capital investments to be approximately $12 billion. Source: earnings call transcript
—

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.